Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$28.4B
1-Year Return
37.22%
This Quarter Return
+2.54%
1 Year Return
+37.22%
3 Year Return
+93.7%
5 Year Return
+199.54%
10 Year Return
+398.51%
AUM
$23.8B
AUM Growth
+$568M
(+2.4%)
Cap. Flow
+$620M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
22.79%
Holding
1,768
New
267
Increased
612
Reduced
459
Closed
423
Top Buys
| 1 |
iShares MSCI India ETF
INDA
|
+$253M |
| 2 |
Broadcom
AVGO
|
+$225M |
| 3 |
Amazon
AMZN
|
+$160M |
| 4 |
Royal Bank of Canada
RY
|
+$132M |
| 5 |
Merck
MRK
|
+$124M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$137M |
| 2 |
Apple
AAPL
|
+$119M |
| 3 |
Bank of Montreal
BMO
|
+$99.6M |
| 4 |
UnitedHealth
UNH
|
+$91.6M |
| 5 |
Comcast
CMCSA
|
+$90.4M |
Sector Composition
| 1 | Financials | 21.86% |
| 2 | Technology | 21.61% |
| 3 | Industrials | 11.81% |
| 4 | Energy | 10.41% |
| 5 | Materials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Telesat
TSAT
$312M
| $460K | ﹤0.01% |
50,533
-5,494
| -10% | -$50K |
|
1077
Twin Disc
TWIN
$189M
| $457K | ﹤0.01% |
38,803
+21,751
| +128% | +$256K |
|
1078
Lemonade
LMND
$3.9B
| $454K | ﹤0.01% |
27,497
-3,131
| -10% | -$51.7K |
|
1079
Kura Oncology
KURA
$695M
| $452K | ﹤0.01% |
+21,933
| New | +$452K |
|
1080
Cboe Global Markets
CBOE
$24.5B
| $450K | ﹤0.01% |
2,646
-2,781
| -51% | -$473K |
|
1081
Aura Biosciences
AURA
$402M
| $446K | ﹤0.01% |
59,055
-12,631
| -18% | -$95.5K |
|
1082
Ingersoll Rand
IR
$31.9B
| $446K | ﹤0.01% |
4,906
+1,597
| +48% | +$145K |
|
1083
Unifirst Corp
UNF
$3.24B
| $445K | ﹤0.01% |
+2,594
| New | +$445K |
|
1084
Celcuity
CELC
$2.65B
| $444K | ﹤0.01% |
27,104
-10,389
| -28% | -$170K |
|
1085
Banner Corp
BANR
$2.34B
| $440K | ﹤0.01% |
8,861
-19,247
| -68% | -$955K |
|
|
GTY
1086
Getty Realty Corp
GTY
$1.62B
| $439K | ﹤0.01% |
+16,467
| New | +$439K |
|
|
NAGE
1087
Niagen Bioscience, Inc. Common Stock
NAGE
$754M
| $431K | ﹤0.01% |
158,057
+24,991
| +19% | +$68.2K |
|
1088
ANI Pharmaceuticals
ANIP
$2.06B
| $429K | ﹤0.01% |
6,742
-8,560
| -56% | -$545K |
|
1089
Harvard Bioscience
HBIO
$19.5M
| $429K | ﹤0.01% |
150,399
+6,344
| +4% | +$18.1K |
|
1090
QCR Holdings
QCRH
$1.34B
| $424K | ﹤0.01% |
+7,068
| New | +$424K |
|
1091
Jabil
JBL
$22.5B
| $422K | ﹤0.01% |
+3,883
| New | +$422K |
|
1092
Coeur Mining
CDE
$9.21B
| $421K | ﹤0.01% |
+74,832
| New | +$421K |
|
1093
TTM Technologies
TTMI
$4.92B
| $420K | ﹤0.01% |
+21,639
| New | +$420K |
|
1094
HUTCHMED
HCM
$2.76B
| $419K | ﹤0.01% |
24,479
-19,626
| -44% | -$336K |
|
1095
Consensus Cloud Solutions
CCSI
$525M
| $418K | ﹤0.01% |
24,352
-11,235
| -32% | -$193K |
|
1096
Vitamin Cottage Natural Grocers
NGVC
$833M
| $415K | ﹤0.01% |
19,592
+6,800
| +53% | +$144K |
|
1097
Zentalis Pharmaceuticals
ZNTL
$118M
| $414K | ﹤0.01% |
101,270
+81,799
| +420% | +$335K |
|
1098
StoneX
SNEX
$4.99B
| $413K | ﹤0.01% |
+8,229
| New | +$413K |
|
1099
Oxford Square Capital
OXSQ
$172M
| $413K | ﹤0.01% |
140,309
+4,322
| +3% | +$12.7K |
|
1100
Arq
ARQ
$310M
| $412K | ﹤0.01% |
67,890
+45,825
| +208% | +$278K |
|